Aderoxine en es it fr

Aderoxine Brand names, Aderoxine Analogs

Aderoxine Brand Names Mixture

  • No information avaliable

Aderoxine Chemical_Formula


Aderoxine RX_link

No information avaliable

Aderoxine fda sheet

Aderoxine msds (material safety sheet)

Aderoxine MSDS

Aderoxine Synthesis Reference

No information avaliable

Aderoxine Molecular Weight

169.178 g/mol

Aderoxine Melting Point

207 oC

Aderoxine H2O Solubility

2.2E+005 mg/L

Aderoxine State


Aderoxine LogP


Aderoxine Dosage Forms


Aderoxine Indication

For the treatment of vitamin B6 deficiency and for the prophylaxis of isoniazid-induced peripheral neuropathy.

Aderoxine Pharmacology

Vitamin B6 (pyridoxine) is a water-soluble vitamin used in the prophylaxis and treatment of vitamin B6 deficiency and peripheral neuropathy in those receiving isoniazid (isonicotinic acid hydrazide, INH). Vitamin B6 has been found to lower systolic and diastolic blood pressure in a small group of subjects with essential hypertension. Hypertension is another risk factor for atherosclerosis and coronary heart disease. Another study showed pyridoxine hydrochloride to inhibit ADP- or epinephrine-induced platelet aggregation and to lower total cholesterol levels and increase HDL-cholesterol levels, again in a small group of subjects. Vitamin B6, in the form of pyridoxal 5'-phosphate, was found to protect vascular endothelial cells in culture from injury by activated platelets. Endothelial injury and dysfunction are critical initiating events in the pathogenesis of atherosclerosis. Human studies have demonstrated that vitamin B6 deficiency affects cellular and humoral responses of the immune system. Vitamin B6 deficiency results in altered lymphocyte differentiation and maturation, reduced delayed-type hypersensitivity (DTH) responses, impaired antibody production, decreased lymphocyte proliferation and decreased interleukin (IL)-2 production, among other immunologic activities.

Aderoxine Absorption

Readily absorbed

Aderoxine side effects and Toxicity

Oral Rat LD50 = 4 gm/kg. Toxic effects include convulsions, dyspnea, hypermotility, diarrhea, ataxia and muscle weakness.

Aderoxine Patient Information

No information avaliable

Aderoxine Organisms Affected

Humans and other mammals